Targeting the DNA damage response in immuno-oncology: developments and opportunities.
Nat Rev Cancer. 2021 Nov;21(11):701-717. doi: 10.1038/s41568-021-00386-6. Epub 2021 Aug 10.
Nat Rev Cancer. 2021.
PMID: 34376827
Review.